Press release
Long Read Sequencing Market CAGR 20.12% Top Trends with Oxford Nanopore Technologies, Pacific Biosciences of California, BaseClear B.V., Future Genomics Technologies, Garvan Institute of Medical
Long Read Sequencing Market
The market for Long Read Sequencing is projected to grow at a compound annual growth rate (CAGR) of 20.12% from 2025 to 2032. This robust growth trajectory indicates a rising interest in advanced sequencing technologies that can enhance our understanding of genetic diseases and facilitate the development of targeted therapies. By 2032, the market is expected to surpass significant valuation thresholds, reflecting increased investment in research, technological innovations, and the growing prevalence of genomic initiatives aimed at improving healthcare outcomes. The integration of long read sequencing into routine clinical practice, coupled with decreasing costs and enhanced accessibility, is likely to further drive this market evolution, enabling researchers and clinicians to harness the full potential of genomic information in their work.
You can access a sample PDF report here: https://www.statsndata.org/download-sample.php?id=7781
The Long Read Sequencing market has emerged as a pivotal segment within the broader genomic sequencing landscape. This innovative technology is transforming the field of molecular biology by enabling researchers to generate longer sequences of DNA and RNA, thus facilitating more comprehensive genomic mapping and genetic analysis. Long read sequencing offers distinct advantages over traditional short read sequencing methods, particularly in its ability to accurately identify structural variants and improve genome assembly for complex genomes.
Recent developments have catalyzed the growth of the long read sequencing market. Key factors include breakthroughs in sequencing technology, which have significantly enhanced accuracy and reduced costs. Additionally, strategic partnerships among leading players in bioinformatics and molecular biology are driving innovation and expanding the application scope of long read sequencing. These advancements are not only advancing academic research but are also influencing personalized medicine, cancer research, and agricultural genomics, thereby offering actionable insights for executives, investors, and decision-makers.
Key Growth Drivers and Trends
Several key growth drivers are propelling the long read sequencing market forward. The increasing emphasis on sustainability in research practices is prompting organizations to adopt high throughput sequencing technologies that minimize waste and resource consumption. Digitization across the healthcare and research sectors is further fueling demand, as researchers seek to leverage data for deeper insights into genetic information.
Transformative trends such as the integration of artificial intelligence (AI) into sequencing data analysis are revolutionizing the field. AI algorithms are being utilized to enhance the accuracy of genomic sequencing and streamline data interpretation, making it easier for researchers to derive meaningful conclusions from complex datasets. Furthermore, product customization is becoming a norm, allowing researchers to tailor sequencing solutions to meet their specific needs.
Emerging technologies such as blockchain are also beginning to find applications in ensuring data integrity and security in genomic research. The convergence of these technologies with long read sequencing is creating a dynamic landscape ripe for innovation. As the market continues to evolve, organizations must stay attuned to these trends to capitalize on new opportunities.
Market Segmentation
The long read sequencing market can be segmented into the following categories:
By Type:
- Single-Molecule Real-Time Sequencing (SMRT)
- Nanopore Sequencing
By Application:
- Academic Research
- Clinical Research
- Hospitals & Clinics
- Pharma & Biotech Entities
- Other
This segmentation allows for a clearer understanding of the diverse applications and methodologies within the long read sequencing market. Each segment plays a critical role in advancing research and clinical diagnostics.
Competitive Landscape
The competitive landscape of the long read sequencing market features several key players that are leading the way in innovation and application.
- Oxford Nanopore Technologies is at the forefront of developing portable sequencing devices, revolutionizing field research capabilities and real-time genomic analysis.
- Pacific Biosciences of California focuses on SMRT sequencing technology, continuously enhancing its platform's capabilities for comprehensive genomic analysis.
- BaseClear B.V. specializes in microbial genomics, leveraging long read sequencing to provide detailed insights into complex microbial communities.
- Future Genomics Technologies is innovating in the bioinformatics space, enhancing data analysis methods for long read sequencing applications.
- Garvan Institute of Medical Research is utilizing long read sequencing to advance cancer genomics, enabling researchers to understand tumor heterogeneity better.
- Genome Transcriptome Facility of Bordeaux is engaged in developing novel applications of long read sequencing for transcriptome analysis, contributing to advancements in gene expression studies.
- NextOmics is focusing on integrating AI with genomic sequencing to improve data interpretation and accuracy.
- Takara Bio is expanding its product offerings to include advanced long read sequencing kits aimed at enhancing research capabilities in molecular biology.
- Quantapore is innovating in sequencing chemistry, aiming to improve the efficiency and cost-effectiveness of long read sequencing.
- Stratos Genomics leverages unique nanopore technology to advance sequencing accuracy and speed.
- MicrobesNG is utilizing long read sequencing for comprehensive microbial genome analysis, enhancing the understanding of complex ecosystems.
- Institute of Integrative Biology of the Cell is applying long read sequencing to unravel complex biological systems and their interactions.
Each of these players is contributing to the dynamic growth of the long read sequencing market through strategic launches, expansions, and partnerships.
Opportunities and Challenges
While the long read sequencing market is ripe with opportunities, it also faces challenges that need to be addressed. Untapped niches, such as the agricultural applications of long read sequencing, present significant growth potential. As consumer expectations shift towards more personalized and sustainable options, the market must also adapt to evolving buyer personas.
Monetization avenues are emerging with the increasing demand for sequencing services across academic, clinical, and commercial sectors. However, regulatory hurdles pose a challenge to market expansion, necessitating clear guidelines and streamlined processes to facilitate research and development. Supply-chain gaps can also impede timely access to sequencing technology, underscoring the need for robust logistics and partnerships to ensure continuity in service delivery.
Technological Advancements
The long read sequencing market is witnessing a wave of technological advancements that are reshaping the landscape. Cutting-edge tools such as AI are enhancing data analysis capabilities, allowing researchers to extract deeper insights from genomic data. Digital twins are being explored for their potential to simulate biological processes, aiding in experimental design and hypothesis testing.
The Internet of Things (IoT) is facilitating real-time data collection and monitoring, while virtual reality applications are being explored for visualizing complex genetic data. Blockchain technology is emerging as a solution for ensuring data integrity and security, particularly in sensitive genomic research.
These advancements are not only improving the efficiency and accuracy of long read sequencing but are also paving the way for new applications in personalized medicine and complex genomic studies.
Research Methodology and Insights
At STATS N DATA, our research methodology employs a robust top-down and bottom-up approach, ensuring comprehensive insights into the long read sequencing market. We gather primary data through expert interviews and surveys, complemented by secondary research from industry reports and academic publications. Our multi-layer triangulation process ensures that our insights are accurate, actionable, and relevant to stakeholders in the market.
By synthesizing this information, we provide a clear picture of current trends, growth opportunities, and challenges within the long read sequencing landscape, positioning STATS N DATA as a trusted authority in genomic sequencing.
The long read sequencing market is poised for substantial growth, driven by technological advancements and an increasing demand for comprehensive genomic insights. As organizations continue to explore the myriad applications of this technology, from cancer research to agricultural genomics, the opportunities for innovation and collaboration are vast. Stakeholders must remain agile and informed to navigate the evolving landscape, ensuring they leverage the full potential of long read sequencing in their research endeavors.
Get 30% Discount On Full Report: https://www.statsndata.org/ask-for-discount.php?id=7781
In the rapidly evolving landscape of genomics, a leading player in the field found itself facing a formidable challenge. Despite making significant strides in developing innovative sequencing technologies, the company was struggling to leverage its long-read sequencing capabilities effectively in an increasingly competitive market. As competitors began to roll out advanced solutions that captured the attention of researchers and clinicians alike, this key player noticed a stagnation in market growth and a decline in customer engagement. The promise of long-read sequencing, which had the potential to unlock new insights into complex genomic structures and diseases, was not being fully realized. The company recognized that without a strategic overhaul, it risked losing its position as a pioneer in the industry, leaving it vulnerable to disruption from more agile rivals.
To address this urgent situation, the company turned to a sophisticated analytical approach that would redefine its market strategy. By harnessing the power of data analytics and market intelligence, a tailored strategy was developed that focused on understanding customer needs, identifying gaps in the existing product offerings, and exploring new avenues for innovation. A comprehensive analysis of user feedback revealed that many researchers were struggling with the complexity and cost of current long-read sequencing solutions. Armed with insights derived from extensive data sets, the company began to streamline its product line, emphasizing user-friendly interfaces and customizable options that catered to specific research requirements. Additionally, the strategy involved enhancing collaboration with academic institutions and research organizations to foster innovation and drive adoption of long-read sequencing technologies. This proactive approach not only addressed existing market challenges but also set the stage for a renewed commitment to customer-centric innovation.
The results of this transformative strategy were nothing short of remarkable. Within a year, the company experienced a significant uptick in market share, reclaiming its status as a leader in the long-read sequencing sector. Customer engagement soared, with an increase in repeat business and a growing base of new clients eager to utilize the enhanced offerings. Moreover, operational efficiency improved dramatically as the streamlined processes reduced time-to-market for new products and innovations. As a direct result of these initiatives, revenue growth accelerated, surpassing initial projections and solidifying the company's position in the genomics market. The ability to effectively harness long-read sequencing not only revitalized the company's prospects but also contributed to advancing scientific research in genomics, ultimately benefiting the broader healthcare ecosystem.
For customization requests, please visit: https://www.statsndata.org/request-customization.php?id=7781
Q: What is long read sequencing?
A: Long read sequencing refers to a type of DNA sequencing technology that is capable of reading long stretches of DNA in a single pass. This method contrasts with short read sequencing, which generates shorter DNA sequences, typically ranging from 50 to 300 base pairs. Long read sequencing can produce reads that are tens of thousands of base pairs in length, with some technologies capable of reading up to a million base pairs. This capability allows for a more comprehensive analysis of complex genomic regions, including repetitive sequences and structural variants, which are often challenging for short read technologies.
Q: How does long read sequencing differ from short read sequencing?
A: The primary difference between long read sequencing and short read sequencing lies in the length of the DNA fragments that are read during the sequencing process. Short read sequencing generates shorter reads, usually less than 300 base pairs, which can lead to challenges in accurately assembling genomes, particularly those with repetitive regions or structural variations. In contrast, long read sequencing can produce reads that exceed 10,000 base pairs, allowing for better resolution of complex genomic regions. Additionally, long read sequencing tends to have lower throughput and can be more expensive than short read methods, but it excels in resolving ambiguities in the genome and capturing full-length transcripts.
Q: What are the advantages of long read sequencing?
A: Long read sequencing offers several advantages. Firstly, its ability to generate long reads enables better assembly of complex genomes, particularly those with repetitive sequences, structural variants, and haplotypes. This capability is crucial for accurately reconstructing genomes from complex organisms. Secondly, long read sequencing provides improved resolution in transcriptomics, facilitating the identification of full-length isoforms and novel transcripts. Thirdly, it enhances the detection of genomic rearrangements and large structural variants that may be missed by short read technologies. Furthermore, long read sequencing can simplify the analysis of challenging regions, such as telomeres and centromeres, and improve the accuracy of metagenomic studies by providing longer context for read alignment.
Q: What are the main applications of long read sequencing?
A: Long read sequencing has a variety of applications across genomics, transcriptomics, and epigenomics. In genomics, it is used for de novo genome assembly, especially for complex organisms such as plants and animals. It is also valuable in the characterization of structural variants and haplotypes. In transcriptomics, long read sequencing is employed to analyze full-length transcripts, allowing for the discovery of novel isoforms and non-coding RNAs. Additionally, it is used in epigenomics for the study of DNA methylation patterns and histone modifications. Other applications include metagenomics, where it aids in the assembly of microbial genomes from environmental samples, and cancer genomics, where it helps identify mutations and structural changes in tumor genomes.
Q: How is long read sequencing used in cancer research?
A: In cancer research, long read sequencing plays a critical role in understanding the genomic landscape of tumors. It is particularly useful for characterizing structural variants, which are often implicated in cancer progression. Long reads can help identify large chromosomal rearrangements, gene fusions, and copy number variations that might be missed by short read technologies. Furthermore, long read sequencing can provide insights into tumor heterogeneity by capturing different alleles and isoforms present within a tumor. This technology also aids in the analysis of the tumor microenvironment and the identification of novel therapeutic targets by enabling comprehensive genomic profiling of cancer samples.
Q: What technologies are used in long read sequencing?
A: Several technologies are available for long read sequencing, with the most prominent being PacBio (Pacific Biosciences) and Oxford Nanopore Technologies. PacBio's Single Molecule, Real-Time (SMRT) sequencing technology uses circular DNA templates to generate long reads with high accuracy. This method allows for the sequencing of individual DNA molecules in real-time. Oxford Nanopore Technologies, on the other hand, utilizes a nanopore-based approach where DNA molecules pass through a nanopore, generating electrical signals that are translated into nucleotide sequences. This technology is notable for its portability and real-time sequencing capabilities. Other technologies include 10x Genomics, which offers a linked-read approach that combines short reads with long-range information, and Bionano Genomics, which focuses on structural variation analysis through optical mapping.
Q: What are the challenges of long read sequencing?
A: Despite its advantages, long read sequencing faces several challenges. One of the main challenges is the higher error rate associated with long reads compared to short reads. While advances in technology have improved accuracy, errors can still occur, particularly in homopolymeric regions. Additionally, long read sequencing is typically more expensive than short read methods, which can limit its accessibility, especially in resource-constrained settings. The data generated by long read sequencing also requires substantial computational resources for analysis and storage, making bioinformatics expertise essential. Furthermore, the throughput of long read sequencing can be lower than that of short read sequencing, which may affect the scalability of certain projects.
Q: How accurate is long read sequencing?
A: The accuracy of long read sequencing varies depending on the technology used. PacBio's SMRT sequencing has improved significantly over the years, with current versions achieving a consensus accuracy of around 99.9% for long reads when using circular consensus sequencing (CCS). Oxford Nanopore Technologies has also made advancements, with accuracy typically ranging from 90% to 99% depending on the specific protocols and conditions. Although long reads tend to have higher error rates than short reads, the ability to produce longer sequences allows for better resolution of complex genomic regions, often compensating for accuracy limitations in certain applications.
Q: What is the cost of long read sequencing?
A: The cost of long read sequencing can vary widely based on the specific technology used, the scale of the project, and the type of analysis performed. As of recent estimates, the cost per base for PacBio sequencing is generally higher than that of short read sequencing, but the price has been decreasing as the technology matures. For example, whole genome sequencing using PacBio might cost several thousand dollars, depending on the complexity of the genome and the depth of coverage required. Oxford Nanopore Technologies offers a range of products, including portable devices that can reduce costs for smaller projects. Overall, while long read sequencing is more expensive than short read methods, the unique insights it provides can justify the investment, especially for complex genomes or specific applications.
Q: How is data analyzed in long read sequencing?
A: Data analysis in long read sequencing involves several steps, including quality control, alignment, assembly, and variant calling. After sequencing, the raw data is subjected to quality control to filter out low-quality reads. Subsequently, long reads are aligned to a reference genome or assembled de novo using specialized software tools that can handle the unique characteristics of long reads. For instance, tools like Canu, Flye, or SMARTdenovo are commonly used for assembly. Variant calling is another critical step where software such as GATK or long read-specific tools identify single nucleotide variants (SNVs) and structural variants (SVs). Post-analysis, researchers may utilize visualization tools to interpret results, and further functional analysis may be performed to understand the biological implications of the findings.
Q: What are the benefits of long read sequencing in genomics?
A: Long read sequencing presents numerous benefits in genomics. One of the most significant advantages is its ability to assemble complex genomes with high accuracy. The longer reads enable researchers to resolve repetitive regions and structural variants that are often problematic for short read technologies. This capability leads to more complete and accurate genomic assemblies, which is particularly important for non-model organisms and those with complex genomes. Long read sequencing also facilitates the study of transcriptomes by allowing researchers to capture full-length transcripts and identify alternative splicing events. Furthermore, it enhances the ability to detect large structural variants and copy number variations, which are critical for understanding genetic diseases and evolutionary biology.
Q: How does long read sequencing impact personalized medicine?
A: Long read sequencing has the potential to significantly impact personalized medicine by providing more comprehensive genomic information about individuals. This technology allows for the identification of rare variants and structural changes that may contribute to disease susceptibility and treatment response. By enabling detailed genomic profiling, long read sequencing can aid in the development of tailored therapies and targeted treatments based on an individual's unique genetic makeup. Additionally, it can enhance the understanding of complex diseases by elucidating the genetic underpinnings of conditions such as cancer, cardiovascular diseases, and neurodegenerative disorders. As personalized medicine continues to evolve, long read sequencing may play a pivotal role in advancing precision health initiatives.
Q: What is the future of long read sequencing?
A: The future of long read sequencing appears promising, with ongoing advancements in technology aiming to improve accuracy, reduce costs, and increase throughput. As sequencing technologies mature, we can expect to see broader adoption in clinical settings, particularly in areas such as oncology, rare disease diagnosis, and pharmacogenomics. Innovations in bioinformatics and data analysis tools will also enhance the ability to interpret complex genomic data generated by long read sequencing. Moreover, the integration of long read sequencing with other omics approaches, such as proteomics and metabolomics, could lead to a more holistic understanding of biological systems. Overall, as the demand for high-quality genomic data continues to grow, long read sequencing is poised to become an essential tool in both research and clinical applications.
Q: How can long read sequencing aid in microbial genomics?
A: Long read sequencing is particularly beneficial in the field of microbial genomics, where it can significantly enhance the assembly and characterization of microbial genomes. Many microorganisms, including bacteria and fungi, have complex genomes that may contain repetitive elements and plasmids that are difficult to resolve using short read sequencing. Long reads enable researchers to assemble complete genomes, including chromosomal and plasmid sequences, leading to a better understanding of microbial diversity, evolution, and pathogenicity. Additionally, long read sequencing can facilitate metagenomic studies by providing longer context for reads, allowing for better assembly of microbial communities from environmental samples. This capability is crucial for studying microbiomes and their roles in health, disease, and ecosystems.
Q: What are the best practices for long read sequencing?
A: Best practices for long read sequencing involve several key considerations to ensure high-quality data and successful outcomes. Firstly, selecting the appropriate library preparation protocols is crucial, as the quality of the input DNA can significantly impact the results. It is important to use high-molecular-weight DNA and minimize fragmentation during sample preparation. Secondly, rigorous quality control should be performed on sequencing data to filter out low-quality reads and ensure reliable results. Thirdly, using appropriate bioinformatics tools for alignment, assembly, and variant calling is essential, as these tools need to be compatible with long reads. Additionally, researchers should consider the specific objectives of their study when choosing sequencing depth and coverage. Finally, thorough documentation and reproducibility of methods are vital to facilitate validation and replication of findings in long read sequencing studies.
Related Reports:
Mobile Charging Robot for Electric Vehicle Market
https://www.statsndata.org/report/mobile-charging-robot-for-electric-vehicle-market-207170
Permanent Dumpster Service Market
https://www.statsndata.org/report/permanent-dumpster-service-market-42008
OpenID Connect Market
https://www.statsndata.org/report/openid-connect-market-36698
Portable EV Charger Market
https://www.statsndata.org/report/portable-ev-charger-market-14090
SAW RF Filters Market
https://www.statsndata.org/report/saw-rf-filters-market-48490
John Jones
Sales & Marketing Head | Stats N Data
Email: sales@statsndata.org
Website: www.statsndata.org
STATS N DATA is a trusted provider of industry intelligence and market research, delivering actionable insights to businesses across diverse sectors. We specialize in helping organizations navigate complex markets with advanced analytics, detailed market segmentation, and strategic guidance. Our expertise spans industries including technology, healthcare, telecommunications, energy, food & beverages, and more.
Committed to accuracy and innovation, we provide tailored reports that empower clients to make informed decisions, identify emerging opportunities, and achieve sustainable growth. Our team of skilled analysts leverages cutting-edge methodologies to ensure every report addresses the unique challenges of our clients.
At STATS N DATA, we transform data into knowledge and insights into success. Partner with us to gain a competitive edge in today's fast-paced business environment. For more information, visit https://www.statsndata.org or contact us today at sales@statsndata.org
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Long Read Sequencing Market CAGR 20.12% Top Trends with Oxford Nanopore Technologies, Pacific Biosciences of California, BaseClear B.V., Future Genomics Technologies, Garvan Institute of Medical here
News-ID: 4147512 • Views: …
More Releases from STATS N DATA
Virtual Executive Assistant Market 19.40% CAGR Growth Led by Boldly Zirtual Virt …
The Virtual Executive Assistant market is poised for significant growth in the coming years, driven by the increasing demand for flexible work solutions and the rising trend of remote work. As organizations seek to enhance productivity while managing costs, the role of virtual assistants has become increasingly vital. Virtual Executive Assistants provide a range of services, including administrative support, scheduling, communication management, and project coordination, all of which can be…
Hedge Fund Market 4.00% CAGR Growth Led by Premier Tech Chronos Bocedi Lachenmei …
The hedge fund market has long been a significant player in the global financial landscape, characterized by its diverse investment strategies and a focus on delivering high returns. Traditionally, hedge funds have attracted wealthier investors, including high-net-worth individuals and institutional investors, due to their potential for higher yields compared to more conventional investment vehicles. As the market continues to evolve, it is projected to grow at a compound annual growth…
Medical Device Manufacturers Market 6.50% CAGR Growth Led by Baxter Abbott Bosto …
The medical device manufacturing market is poised for significant growth in the coming years, reflecting advancements in technology, an aging population, and an increasing prevalence of chronic diseases. The market is projected to grow at a compound annual growth rate (CAGR) of 6.50% from 2025 to 2032. This growth is driven by the continuous demand for innovative medical devices that enhance patient care, improve diagnostic accuracy, and support minimally invasive…
Agrotechnology Market 16.50% CAGR Growth Led by 3M Letbon Johnson Eastman Cpfilm …
The agrotechnology market is poised for significant growth, driven by advancements in technology and the increasing need for sustainable agricultural practices. As global food demand escalates due to population growth and changing dietary preferences, the agrotechnology sector is evolving to provide innovative solutions that enhance productivity and efficiency in farming. This includes the integration of precision agriculture, biotechnology, and data analytics, which enable farmers to optimize resource usage and improve…
More Releases for Long
Simplifying Long-Distance Moves with Austin Long Distance Movers
Relocating to a new home, especially over a long distance, can be both an exciting and challenging endeavor. The need for reliable assistance is crucial for ensuring a smooth transition. For residents in Austin, finding experienced movers is now simpler with Austin Melrose Movers and Packers Local & Long Distance Moving Company, a name synonymous with trust and professionalism in the moving industry.
Why Choose Professional Long Distance Movers in Austin?
Moving…
U.S. Long Term Care Software Market: Long-Term Value & Growth Seen Ahead
A Latest intelligence report published by Archive Market Research (AMR) with title "U.S. Long Term Care Software Market Outlook to 2032". A detailed study accumulated to offer Latest insights about acute features of the U.S. Long Term Care Software market. This report provides a detailed overview of key factors in the U.S. Long Term Care Software Market and factors such as driver, restraint, past and current trends, regulatory scenarios and…
Winkler Kurtz LLP - Long Island Lawyers Stands Out Among Long Island's Top Perso …
With decades of combined experience, we've built our reputation as one of the leading personal injury firms in Long Island. By providing compassionate support, expert legal guidance, and a proven track record of success, we stand out as the go-to choice when Long Islanders search for "personal injury lawyers near me" or "personal injury lawyers nearby."
At Winkler Kurtz LLP - Long Island Lawyers, we pride ourselves on being a dedicated…
Long Term Care Software Market - Transforming Long-Term Care: Software Solutions …
Newark, New Castle, USA: The "Long Term Care Software Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Long Term Care Software Market: https://www.growthplusreports.com/report/long-term-care-software-market/8527
This latest report researches the…
Investigation announced for Long-Term Investors in shares of SCWorx Corp. (NASDA …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of SCWorx Corp.
Investors who are current long term investors in SCWorx Corp. (NASDAQ: WORX) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: WORX stocks follows a lawsuit filed against SCWorx Corp. over…
TRENDnet launches long-range PoE+ switches for long-distance networking applicat …
TRENDnet® (www.TRENDnet.com), a global leader in reliable SMB and consumer networking and surveillance solutions, is eager to announce the launch of two new long-range gigabit PoE+ switches, allowing users to network PoE devices for up to double the distance of the current standard.
TRENDnet’s 5-Port Gigabit Long Range PoE+ Switch (TPE-LG50) and the 8-Port Gigabit Long Range PoE+ Switch (TPE-LG80) each feature a DIP switch to extend the PoE+ signal up…
